The Influence of the Haemodialysis Procedure on Platelets, Coagulation and Fibrinolysis

Abstract

In end-stage renal disease, in particularly when treated with haemodialysis, the function of platelets, coagulation and fibrinolytic systems can be disturbed, thus contributing to either thrombotic or bleeding complications. It is important to know whether the currently used haemodialysis procedure itself (by biocompatible membranes and better anticoagulation with nandroparin) affects platelets, coagulation or fibrinolysis. In 15 patients who had been treated with chronic haemodialysis, we measured and compared platelet aggregation (induced by adenosine diphosphate, collagen and epinephrine), the markers of coagulation and fibrinolysis activation (thrombin-antithrombin complexes, thrombin fragments F1+2, D-dimer), and fibrinolytic parameters, i.e. fibrinogen, plasminogen, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 antigen and activity, before and immediately after the regular haemodialysis sessions. We did not find differences between pre- and post-haemodialysis platelet aggregation induced with all agents. Markers of coagulation and fibrinolysis activation remained unchanged during the process of haemodialysis. However, in post-haemodialysis samples, t-PA activity was significantly increased. Other fibrinolytic parameters remained unchanged. In conclusion, our results showed that the current technique of haemodialysis procedure does not affect platelet aggregation or activate coagulation, and therefore, does not contribute to a thrombotic tendency. However, it does directly affect fibrinolysis through activation of t-PA, which might be clinically relevant since this could increase the bleeding tendency in some haemodialysis patients.

Impact of Chronic Kidney Disease on Outcomes of Surgical Resection for Primary Colorectal Cancer

“…30,31 In this regard, however, CKD stage progression was not correlated with the amount of blood loss during colorectal surgery (Table 2). Frequent blood transfusion during surgery was deemed to reflect a prevalence of preoperative hypoalbuminemia and anemia in patients with stages 3 to 4 or 5 CKD.…”

The hypercoagulability paradox of chronic kidney disease: The role of fibrinogen

“…The mechanisms for this remain to be fully explained, although some studies show decreased levels of fibrinogen and vWF after dialysis, other suggest changes arise from increased tPA levels following dialysis. 20, 21 …”

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial

“…In most studies LMWHs are injected at the inlet line [8–20] or the administration site is not specified [21–24]. In the information leaflet of tinzaparin, enoxaparin and nadroparin, administration via the arterial line is recommended [25], whereas in guidelines no recommendation concerning the administration site is provided [1].…”